Acute management and research of stroke in Taiwan

An update

Chih Ping Chung, Han Hwa Hu

Research output: Contribution to journalArticle

Abstract

The presentation discussed certain issues in the management and research of cerebrovascular diseases in Taiwan. In the first part of the presentation, the acute management of stroke in Taiwan, I have revealed the results of the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study (rt-PA). TTT-AIS was a multicentre, observational study, which enrolled 244 eligible patients with acute ischemic stroke from 23 hospitals from December 2004 to July 2008. The standard-dose group (0.9 mg/kg) had higher rates of symptomatic ICH and mortality within three months, twice that of the lower-dose group. This pattern was more prominent in older patients. Besides, significantly lower independence rate was also observed among patients ≥ 70 years old receiving standard-dose than lower-dose. This study suggests that the standard dose of alteplase 0.9 mg/kg may not be optimal for treating aged Chinese. However, the optimal dose of rt-PA for ischemic stroke in Chinese should be based on more broad and convincing evidences. Randomized trials of lower versus higher dose of rt-PA are needed. The second part of the presentation discussed about the relationship between age-related cerebral white matter lesions (leukoaraiosis) and jugular venous reflux (JVR), one of the plenty researches about cerebral venous insufficiency in Taiwan. The presentation introduced current evidences and rationales favoring venous ischemia as a role in the pathophysiology of leukoaraiosis.

Original languageEnglish
Pages (from-to)828-829
Number of pages2
JournalClinical Neurology
Volume50
Issue number11
DOIs
Publication statusPublished - Dec 1 2010
Externally publishedYes

Fingerprint

Taiwan
Stroke
Leukoaraiosis
Research
Thrombolytic Therapy
Cerebrovascular Disorders
Venous Insufficiency
Tissue Plasminogen Activator
Multicenter Studies
Observational Studies
Neck
Ischemia
Mortality

Keywords

  • Ischemic stroke
  • Jugular venous reflux
  • Leukoaraiosis
  • rtPA
  • Stroke treatment

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Acute management and research of stroke in Taiwan : An update. / Chung, Chih Ping; Hu, Han Hwa.

In: Clinical Neurology, Vol. 50, No. 11, 01.12.2010, p. 828-829.

Research output: Contribution to journalArticle

Chung, Chih Ping ; Hu, Han Hwa. / Acute management and research of stroke in Taiwan : An update. In: Clinical Neurology. 2010 ; Vol. 50, No. 11. pp. 828-829.
@article{55971752f8eb463fa4095f158f1ff46d,
title = "Acute management and research of stroke in Taiwan: An update",
abstract = "The presentation discussed certain issues in the management and research of cerebrovascular diseases in Taiwan. In the first part of the presentation, the acute management of stroke in Taiwan, I have revealed the results of the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study (rt-PA). TTT-AIS was a multicentre, observational study, which enrolled 244 eligible patients with acute ischemic stroke from 23 hospitals from December 2004 to July 2008. The standard-dose group (0.9 mg/kg) had higher rates of symptomatic ICH and mortality within three months, twice that of the lower-dose group. This pattern was more prominent in older patients. Besides, significantly lower independence rate was also observed among patients ≥ 70 years old receiving standard-dose than lower-dose. This study suggests that the standard dose of alteplase 0.9 mg/kg may not be optimal for treating aged Chinese. However, the optimal dose of rt-PA for ischemic stroke in Chinese should be based on more broad and convincing evidences. Randomized trials of lower versus higher dose of rt-PA are needed. The second part of the presentation discussed about the relationship between age-related cerebral white matter lesions (leukoaraiosis) and jugular venous reflux (JVR), one of the plenty researches about cerebral venous insufficiency in Taiwan. The presentation introduced current evidences and rationales favoring venous ischemia as a role in the pathophysiology of leukoaraiosis.",
keywords = "Ischemic stroke, Jugular venous reflux, Leukoaraiosis, rtPA, Stroke treatment",
author = "Chung, {Chih Ping} and Hu, {Han Hwa}",
year = "2010",
month = "12",
day = "1",
doi = "10.5692/clinicalneurol.50.828",
language = "English",
volume = "50",
pages = "828--829",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "11",

}

TY - JOUR

T1 - Acute management and research of stroke in Taiwan

T2 - An update

AU - Chung, Chih Ping

AU - Hu, Han Hwa

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The presentation discussed certain issues in the management and research of cerebrovascular diseases in Taiwan. In the first part of the presentation, the acute management of stroke in Taiwan, I have revealed the results of the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study (rt-PA). TTT-AIS was a multicentre, observational study, which enrolled 244 eligible patients with acute ischemic stroke from 23 hospitals from December 2004 to July 2008. The standard-dose group (0.9 mg/kg) had higher rates of symptomatic ICH and mortality within three months, twice that of the lower-dose group. This pattern was more prominent in older patients. Besides, significantly lower independence rate was also observed among patients ≥ 70 years old receiving standard-dose than lower-dose. This study suggests that the standard dose of alteplase 0.9 mg/kg may not be optimal for treating aged Chinese. However, the optimal dose of rt-PA for ischemic stroke in Chinese should be based on more broad and convincing evidences. Randomized trials of lower versus higher dose of rt-PA are needed. The second part of the presentation discussed about the relationship between age-related cerebral white matter lesions (leukoaraiosis) and jugular venous reflux (JVR), one of the plenty researches about cerebral venous insufficiency in Taiwan. The presentation introduced current evidences and rationales favoring venous ischemia as a role in the pathophysiology of leukoaraiosis.

AB - The presentation discussed certain issues in the management and research of cerebrovascular diseases in Taiwan. In the first part of the presentation, the acute management of stroke in Taiwan, I have revealed the results of the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study (rt-PA). TTT-AIS was a multicentre, observational study, which enrolled 244 eligible patients with acute ischemic stroke from 23 hospitals from December 2004 to July 2008. The standard-dose group (0.9 mg/kg) had higher rates of symptomatic ICH and mortality within three months, twice that of the lower-dose group. This pattern was more prominent in older patients. Besides, significantly lower independence rate was also observed among patients ≥ 70 years old receiving standard-dose than lower-dose. This study suggests that the standard dose of alteplase 0.9 mg/kg may not be optimal for treating aged Chinese. However, the optimal dose of rt-PA for ischemic stroke in Chinese should be based on more broad and convincing evidences. Randomized trials of lower versus higher dose of rt-PA are needed. The second part of the presentation discussed about the relationship between age-related cerebral white matter lesions (leukoaraiosis) and jugular venous reflux (JVR), one of the plenty researches about cerebral venous insufficiency in Taiwan. The presentation introduced current evidences and rationales favoring venous ischemia as a role in the pathophysiology of leukoaraiosis.

KW - Ischemic stroke

KW - Jugular venous reflux

KW - Leukoaraiosis

KW - rtPA

KW - Stroke treatment

UR - http://www.scopus.com/inward/record.url?scp=84856367359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856367359&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.50.828

DO - 10.5692/clinicalneurol.50.828

M3 - Article

VL - 50

SP - 828

EP - 829

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 11

ER -